These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2642482)

  • 41. Platelet prostacyclin binding in smokers.
    Jaschonek K; Weisenberger H; Tidow S; Daiss W; Renn W; Ostendorf P
    J Lab Clin Med; 1986 Aug; 108(2):88-95. PubMed ID: 3016128
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Decrease of prostaglandin I2 binding sites in thyroid cancer.
    Virgolini I; Hermann M; Sinzinger H
    Br J Cancer; 1988 Nov; 58(5):584-8. PubMed ID: 2464364
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epoprostenol (prostacyclin, PGI2) binding and activation of adenylate cyclase in platelets of diabetic and control subjects.
    Shepherd GL; Lewis PJ; Blair IA; de Mey C; MacDermot J
    Br J Clin Pharmacol; 1983 Jan; 15(1):77-81. PubMed ID: 6342639
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Human prostacyclin platelet receptors in diabetes mellitus.
    Modesti PA; Fortini A; Gensini GF; Vanni D; Prisco D; Abbate R
    Thromb Res; 1991 Sep; 63(5):541-8. PubMed ID: 1755006
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of binding of a specific antagonist, [3H]-SQ 29,548, to soluble thromboxane A2/prostaglandin H2 (TP) receptors in human platelet membranes.
    Monshizadegan H; Hedberg A; Webb ML
    Life Sci; 1992; 51(6):431-7. PubMed ID: 1386132
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of prostaglandin-receptors in human and rat liver: interspecies differences at the prostaglandin receptor-level.
    Virgolini I; Müller C; Hermann M; Schütz W; Sinzinger H
    Prostaglandins; 1988 Dec; 36(6):807-18. PubMed ID: 2469102
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential solubilization of membrane lipids by detergents: coenrichment of the sheep brain serotonin 5-HT1A receptor with phospholipids containing predominantly saturated fatty acids.
    Banerjee P; Dasgupta A; Chromy BA; Dawson G
    Arch Biochem Biophys; 1993 Aug; 305(1):68-77. PubMed ID: 8342957
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [3H]S-145 and [125I]I-S-145-OH: new radioligands for platelet thromboxane A2 receptor with low nonspecific binding and high binding affinity for various receptor preparations.
    Ushikubi F; Nakajima M; Yamamoto M; Ohtsu K; Kimura Y; Okuma M; Uchino H; Fujiwara M; Narumiya S
    Eicosanoids; 1989; 2(1):21-7. PubMed ID: 2534469
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biochemical and pharmacological activity of arene-fused prostacyclin analogues on human platelets.
    Jakubowski JA; Utterback BG; Mais DE; Hardinger SA; Braish TF; Nevill CR; Fuchs PL
    Prostaglandins; 1994 Mar; 47(3):189-201. PubMed ID: 8016389
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acute reversible reduction of PGI2 platelet receptors after iloprost infusion in man.
    Modesti PA; Fortini A; Poggesi L; Boddi M; Abbate R; Gensini GF
    Thromb Res; 1987 Dec; 48(6):663-9. PubMed ID: 2448896
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Solubilization of the benzodiazepine/gamma-aminobutyric acid receptor complex: comparison of the detergents octylglucopyranoside and 3-[(3-cholamidopropyl)-dimethylammonio]1-propanesulfonate (CHAPS).
    Hammond JR; Martin IL
    J Neurochem; 1986 Oct; 47(4):1161-71. PubMed ID: 3018163
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Heterogeneity of solubilized muscarinic cholinergic receptors: binding and hydrodynamic properties.
    Baron B; Gavish M; Sokolovsky M
    Arch Biochem Biophys; 1985 Jul; 240(1):281-96. PubMed ID: 4015105
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Solubilization of receptor for pituitary adenylate cyclase activating polypeptide from bovine brain.
    Masuda Y; Ohtaki T; Kitada C; Tsuda M; Arimura A; Fujino M
    Biochem Biophys Res Commun; 1990 Oct; 172(2):709-14. PubMed ID: 2173577
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impaired platelet prostacyclin receptor activity: a monozygotic twin study discordant for spinal cord injury.
    Kahn N; Sinha A; Bauman W
    Clin Physiol; 2001 Jan; 21(1):60-6. PubMed ID: 11168298
    [TBL] [Abstract][Full Text] [Related]  

  • 55. TEI-9063, a stable and highly specific prostacyclin analogue for the prostacyclin receptor in mastocytoma P-815 cells.
    Negishi M; Hashimoto H; Yatsunami K; Kurozumi S; Ichikawa A
    Prostaglandins; 1991 Sep; 42(3):225-37. PubMed ID: 1723528
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Covalent affinity labeling, detergent solubilization, and fluid-phase characterization of the rabbit neutrophil formyl peptide chemotaxis receptor.
    Marasco WA; Becker KM; Feltner DE; Brown CS; Ward PA; Nairn R
    Biochemistry; 1985 Apr; 24(9):2227-36. PubMed ID: 3995012
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differential solubilization of rat liver sigma 1 and sigma 2 receptors: retention of sigma 2 sites in particulate fractions.
    Torrence-Campbell C; Bowen WD
    Eur J Pharmacol; 1996 May; 304(1-3):201-10. PubMed ID: 8813603
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Solubilization of peripheral-type benzodiazepine binding sites from cat cerebral cortex.
    Awad M; Gavish M
    J Neurochem; 1989 Jun; 52(6):1880-5. PubMed ID: 2723642
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Age related changes of platelet prostacyclin receptors in humans.
    Modesti PA; Fortini A; Abbate R; Gensini GF
    Eur J Clin Invest; 1985 Aug; 15(4):204-8. PubMed ID: 2995049
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prostaglandin endoperoxide analogues which are both thromboxane receptor antagonists and prostacyclin mimetics.
    Armstrong RA; Jones RL; MacDermot J; Wilson NH
    Br J Pharmacol; 1986 Mar; 87(3):543-51. PubMed ID: 3026540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.